Clinical Efficacy of Two Different Methods to Initiate Sensor-Augmented Insulin Pumps: A Randomized Controlled Trial

Table 2

Glycemic outcomes.

⁢	Baseline, mean ± SD			End of study, mean ± SD			Difference from baseline, MDC (95% CI, )
	CGM pre-CSII	CGM post-CSII		CGM pre-CSII	CGM post-CSII		CGM pre-CSII	CGM post-CSII
, %			0.92			0.90	(−1.18, ; )	(−1.02, −0.11; )
Average interstitial glucose, mg/dL			0.72			0.31	(, ; )	(−48, −2; )
% capillary glucose levels <70 mg/dL			0.60			0.03	(, ; )	(, 16; )
% capillary glucose levels >180 mg/dL			0.06			0.47	7.0 (.4, 5.4; )	11.4 (, 40.1; )
Average AUC <70 mg/dL/day			0.35			0.01	(, ; )	(, 0.6; )
Average AUC >180 mg/dL/day			0.67			0.42	(, ; )	(, ; )
Severe hypoglycemia events			0.71			0.03	(, ; )	(, 1.0; )

RT-CGM pre-CSII: real-time continuous glucose monitoring before continuous subcutaneous insulin infusion; RT-CGM post-CSII: real-time continuous glucose monitoring after continuous subcutaneous insulin infusion; MDC: mean difference in change; CI: confidence interval.